Regulatory News
Wednesday, April 27, 2016
BRIEF-Ocular Therapeutix says completes end-of-phase 2 review with FDA for OTX-TP for glaucoma and ocular hypertension
* Says completes end-of-phase 2 review with FDA for OTX-TP
for glaucoma and ocular hypertension
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment